- Friday, August 18, 2023
7:30 AM – 5:00 PM
Welcome
7:30 AM – 5:00 PM
Registration Hours
Location:Essex Foyer
8:00 AM – 8:15 AM
Welcome
8:00 AM – 8:15 AM
WelcomeLocation:Essex Center/SouthCo-Chair: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Co-Chair###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Co-Chair: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### 8:15 AM – 8:30 AM
8 - Session 9: Updates in ND FLT3 AML
8:15 AM – 8:30 AM
Session 9: Updates in ND FLT3 AMLLocation:Essex Center/SouthPresenter: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Presenter###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Presenter: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### 8:30 AM – 9:00 AM
Live Q&A
8:30 AM – 9:00 AM
Case Discussions in AMLLocation:Essex Center/SouthModerator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Panelist: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
Panelist: – University of Rochester Medical Center, Wilmot Cancer Institute
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Moderator###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Moderator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### @@@ Amir T. Fathi, MD – Harvard Medical School; Center for Leukemia, Mass General Cancer Center ### 1533702###Panelist###Associate Professor of Medicine; Harvard Medical School, Program Director, Leukemia, MGH###Harvard Medical School; Center for Leukemia, Mass General Cancer Center###Panelist: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
### @@@ Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Panelist###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Panelist: – University of Rochester Medical Center, Wilmot Cancer Institute
### 9:00 AM – 9:35 AM
9 - Session 10: First Line Treatment of CLL/SLL with Bruton 's Tyrosine Kinase Inhibitors: Seeking Lasting Results
9:00 AM – 9:35 AM
Session 10: First Line Treatment of CLL/SLL with Bruton 's Tyrosine Kinase Inhibitors: Seeking Lasting ResultsLocation:Essex Center/SouthPresenter: – Weill Cornell Medicine
John N. Allan, MD – Weill Cornell Medicine ### 748659###Presenter###Associate Professor of Clinical Medicine###Weill Cornell Medicine###Presenter: – Weill Cornell Medicine
### 9:35 AM – 9:45 AM
Live Q&A
9:35 AM – 9:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Speaker: – Weill Cornell Medicine
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Moderator###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Moderator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### @@@ John N. Allan, MD – Weill Cornell Medicine ### 748659###Speaker###Associate Professor of Clinical Medicine###Weill Cornell Medicine###Speaker: – Weill Cornell Medicine
### 9:45 AM – 9:50 AM
Exhibit Hall
9:50 AM – 10:50 AM
Non-CME Innvoation Theater
9:50 AM – 10:50 AM
Non-CME Innovation Theater - Sponsored by Rigel
Location:Essex North
10:50 AM – 11:00 AM
Exhibit Hall
10:50 AM – 11:00 AM
Exhibit Hall Break
11:00 AM – 11:35 AM
10 - Session 11: What Are the Latest Strategies for Relapsed CLL and What Is on the Horizon?
11:00 AM – 11:35 AM
Session 11: What Are the Latest Strategies for Relapsed CLL and What Is on the Horizon? Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute / Harvard Medical School
Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School ### 748660###Presenter###Director of Clinical Research, Division of Lymphoma / Associate Professor of Medicine###Dana-Farber Cancer Institute / Harvard Medical School###Presenter: – Dana-Farber Cancer Institute / Harvard Medical School
###
11:35 AM – 11:45 AM
Live Q&A
11:35 AM – 11:45 AM
Live Q&ALocation:Essex Center/SouthSpeaker: – Dana-Farber Cancer Institute / Harvard Medical School
Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School ### 748660###Speaker###Director of Clinical Research, Division of Lymphoma / Associate Professor of Medicine###Dana-Farber Cancer Institute / Harvard Medical School###Speaker: – Dana-Farber Cancer Institute / Harvard Medical School
### 11:45 AM – 12:20 PM
11 - Session 12: Orphan Hematologic Malignancies --Systemic Mastocytosis and Myeloid-Lymphoid Neoplasms: Classification, Diagnosis, Genetics and Targeted Therapeutic Options
11:45 AM – 12:20 PM
Session 12: Orphan Hematologic Malignancies --Systemic Mastocytosis and Myeloid-Lymphoid Neoplasms: Classification, Diagnosis, Genetics and Targeted Therapeutic OptionsLocation:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute; Harvard Medical School
Daniel J. DeAngelo, MD, PhD – Dana-Farber Cancer Institute; Harvard Medical School ### 692263###Presenter###Chief of the Division of Leukemia; Professor of Medicine###Dana-Farber Cancer Institute; Harvard Medical School###Presenter: – Dana-Farber Cancer Institute; Harvard Medical School
### 12:20 PM – 12:30 PM
Live Q&A
12:20 PM – 12:30 PM
Live Q&ALocation:Essex Center/SouthModerator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
Speaker: – Dana-Farber Cancer Institute; Harvard Medical School
Jessica K. Altman, MD – Robert H. Lurie Comprehensive Cancer Center; Northwestern University ### 944495###Moderator###Professor of Medicine###Robert H. Lurie Comprehensive Cancer Center; Northwestern University###Moderator: – Robert H. Lurie Comprehensive Cancer Center; Northwestern University
### @@@ Daniel J. DeAngelo, MD, PhD – Dana-Farber Cancer Institute; Harvard Medical School ### 692263###Speaker###Chief of the Division of Leukemia; Professor of Medicine###Dana-Farber Cancer Institute; Harvard Medical School###Speaker: – Dana-Farber Cancer Institute; Harvard Medical School
### 12:30 PM – 12:35 PM
Exhibit Hall
12:30 PM – 12:35 PM
Break
12:35 PM – 1:35 PM
Lunch
1:35 PM – 2:10 PM
12 - Session 13: Effective Risk Stratification and Expert Treatment Selection Advice for Patients with Myelodysplastic Syndromes
1:35 PM – 2:10 PM
Session 13: Effective Risk Stratification and Expert Treatment Selection Advice for Patients with Myelodysplastic SyndromesLocation:Essex Center/SouthPresenter: – Yale New Haven Health
Amer M. Zeidan, MBBS, MHS (he/him/his) – Yale New Haven Health ### 703522###Presenter###Associate Professor###Yale New Haven Health###Presenter: – Yale New Haven Health
### he/him/his2:10 PM – 2:20 PM
Live Q&A
2:10 PM – 2:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – University of Rochester Medical Center, Wilmot Cancer Institute
Speaker: – Yale New Haven Health
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Moderator###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Moderator: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Amer M. Zeidan, MBBS, MHS (he/him/his) – Yale New Haven Health ### 703522###Speaker###Associate Professor###Yale New Haven Health###Speaker: – Yale New Haven Health
### he/him/his2:20 PM – 3:05 PM
13 - Session 14: What Is New in Relapsed AML With a Focus on Menin and IDH Inhibitors?
2:20 PM – 2:55 PM
Session 14: What Is New in Relapsed AML With a Focus on Menin and IDH Inhibitors?Location:Essex Center/SouthPresenter: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
Amir T. Fathi, MD – Harvard Medical School; Center for Leukemia, Mass General Cancer Center ### 1533702###Presenter###Associate Professor of Medicine; Harvard Medical School, Program Director, Leukemia, MGH###Harvard Medical School; Center for Leukemia, Mass General Cancer Center###Presenter: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
### 2:55 PM – 3:05 PM
Live Q&A
2:55 PM – 3:05 PM
Live Q&ALocation:Essex Center/SouthModerator: – University of Rochester Medical Center, Wilmot Cancer Institute
Speaker: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Moderator###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Moderator: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Amir T. Fathi, MD – Harvard Medical School; Center for Leukemia, Mass General Cancer Center ### 1533702###Speaker###Associate Professor of Medicine; Harvard Medical School, Program Director, Leukemia, MGH###Harvard Medical School; Center for Leukemia, Mass General Cancer Center###Speaker: – Harvard Medical School; Center for Leukemia, Mass General Cancer Center
### 3:05 PM – 3:35 PM
Exhibit Hall
3:05 PM – 3:35 PM
Exhibit Hall Break
3:35 PM – 3:52 PM
14 - Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - Yes
3:35 PM – 3:52 PM
Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - YesLocation:Essex Center/SouthPresenter: – City of Hope
Andrew Artz, MD, MS – City of Hope ### 1649062###Presenter###Professor###City of Hope###Presenter: – City of Hope
### 3:52 PM – 4:10 PM
14 - Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - No
3:52 PM – 4:10 PM
Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - NoLocation:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute, Harvard Medical School
Richard M. Stone, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 972507###Presenter###Chief of Staff; Professor of Medicine###Dana-Farber Cancer Institute, Harvard Medical School###Presenter: – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his4:10 PM – 4:20 PM
14 - Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT
4:10 PM – 4:20 PM
Session 15: Debate - MRD+ Patients with AML Should Proceed with HSCT - DiscussionLocation:Essex Center/SouthModerator: – University of Rochester Medical Center, Wilmot Cancer Institute
Panelist: – City of Hope
Panelist: – Dana-Farber Cancer Institute, Harvard Medical School
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Moderator###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Moderator: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Andrew Artz, MD, MS – City of Hope ### 1649062###Panelist###Professor###City of Hope###Panelist: – City of Hope
### @@@ Richard M. Stone, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 972507###Panelist###Chief of Staff; Professor of Medicine###Dana-Farber Cancer Institute, Harvard Medical School###Panelist: – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his4:20 PM – 4:55 PM
13 - Session 16: Risk Stratification in ALL and Approach to Treatment
4:20 PM – 4:55 PM
Session 16: Risk Stratification in ALL and Approach to TreatmentLocation:Essex Center/SouthPresenter: – University of Rochester Medical Center, Wilmot Cancer Institute
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Presenter###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Presenter: – University of Rochester Medical Center, Wilmot Cancer Institute
### 4:55 PM – 5:05 PM
Live Q&A
4:55 PM – 5:05 PM
Live Q&ALocation:Essex Center/SouthSpeaker: – University of Rochester Medical Center, Wilmot Cancer Institute
Panelist: – City of Hope
Kristen O'Dwyer, MD – University of Rochester Medical Center, Wilmot Cancer Institute ### 1544763###Speaker###Associate Professor of Medicine and Oncology###University of Rochester Medical Center, Wilmot Cancer Institute###Speaker: – University of Rochester Medical Center, Wilmot Cancer Institute
### @@@ Andrew Artz, MD, MS – City of Hope ### 1649062###Panelist###Professor###City of Hope###Panelist: – City of Hope
### 5:05 PM – 5:45 PM
13 - Special Session: Exciting Advances in Myelofibrosis
5:05 PM – 5:45 PM
Special Session: Exciting Advances in MyelofibrosisLocation:Essex Center/SouthSpeaker: – Massachusetts General Hospital
Gabriela S. Hobbs, MD (she/her/hers) – Massachusetts General Hospital ### 854690###Speaker###Clinical Director, Leukemia Service.###Massachusetts General Hospital###Speaker: – Massachusetts General Hospital
### she/her/hers
